Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates339
Factors influencing COVID-19 vaccination intention among overseas and domestic Chinese university students: a cross-sectional survey280
Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized tria164
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature140
Assessment of caregiver willingness to vaccinate their children against COVID-19 in Saudi Arabia: a cross-sectional study101
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals82
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam76
Correction74
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak72
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling65
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence64
Plasma therapy: a passive resistance against the deadliest63
Human vaccines & immunotherapeutics news: July 202062
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain60
Human vaccines & immunotherapeutics: News October 202258
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202157
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China56
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer56
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study56
COVID-19 vaccine acceptance and hesitancy among ethnic minorities in Hong Kong55
Vaccine manufacturing is essential to ensure access54
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’54
Human vaccines & immunotherapeutics: news October 202152
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China52
HV&I Reviewer Highlight49
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector49
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention47
Improving Tdap maternal immunization rate in Saudi Arabia47
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality46
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons46
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals46
Human vaccines and immunotherapeutics: News December 202345
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study45
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia44
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies44
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents43
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines43
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control43
Pertactin deficiency of Bordetella pertussis : Insights into epidemiology, and perspectives on surveillance and public health impact42
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children40
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have40
0.055635929107666